Search results
Jonathan Lim is a biotech entrepreneur and CEO of Erasca, a company he co-founded to erase cancer. He is also an advisor and board member of ARCH portfolio companies, including Boundless Bio and Maze Therapeutics.
Jonathan Lim is a triple-qualified English solicitor, Singapore advocate, and New York lawyer with a focus on complex international disputes. He has a broad practice representing clients in all types of commercial and investment treaty arbitrations seated in common law and civil law jurisdictions worldwide, including England, New York, Singapore, Hong Kong, France, Brazil, The Netherlands, and ...
- 49 Park Lane, W1K 1PS, London
- jonathan.lim@wilmerhale.com
- 4402.1B
- Partner
Apr 19, 2022 · Jonathan Lim, M.D. launches City Hill Arts, a film production and financing company with a mission to revitalize people, planet and perspective. He reveals his upcoming slate of projects, including The Penguin and the Fisherman, Thirst, Newsflash and The Belgariad.
- Matt Grobar
Jonathan is Chairman and CEO of Erasca, which he co-founded in July 2018 with a mission to erase cancer. He is a physician-turned-venturepreneur who, from 2003 to 2018, was a leader and founding investor of four other biotechnology startups that delivered novel therapies for the benefit of patients globally, raised a combined $1 billion in capital and generated more than $4 billion of ...
Talent Jonathan Lim, M.D. City Hill Founder Dr. Jonathan Lim is a physician-turned-venturepreneur at City Hill and ARCH Venture who founds, funds and leads mission-driven for-profit and non-profit ventures dedicated to revitalizing people, planet and perspective. Dr. Lim is a life sciences industry pioneer who has
Jonathan Lim, M.D., is a physician-turned-venturepreneur who has founded, funded and led multiple biotechnology startups that have brought life-changing therapeutics to patients globally while collectively generating approximately $10 billion in shareholder value.
Jonathan Lim is Founder of Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company that is a portfolio company of City Hill Ventures, LLC, a health care investment firm that he founded in 2010. Jonathan is also a Board Director of Bionomics Ltd (ASX: BNO). Prior to Ignyta, Jonathan’s experience includes Chairman, CEO and
